Innovus Pharmaceuticals (INNV) Social Stream



Innovus Pharmaceuticals (INNV): $6.86

0.33 (+5.05%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

InnovAge Holding Corp (INNV) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering INNV.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
6 $31 $17 $26 $6.49 300.62%

The Trend in the Analyst Price Target


INNV's average price target has moved down $2.8 over the prior 99 days.

INNV reports an average of 54.94% for its upside potential over the past 24 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-20 6 31 17 26.00 12.71 104.56%
2021-09-19 6 31 17 26.00 14.00 85.71%
2021-09-18 6 31 17 26.00 14.00 85.71%
2021-09-11 5 31 23 27.80 14.95 85.95%
2021-09-04 5 31 23 27.80 15.27 82.06%
2021-08-28 5 31 23 27.80 15.25 82.3%
2021-08-14 5 31 19 27.00 16.00 68.75%
2021-08-07 5 31 26 28.40 17.22 64.92%
2021-08-05 5 31 26 28.40 16.98 67.26%
2021-08-01 5 31 26 28.40 16.86 68.45%
2021-07-24 5 31 26 28.40 17.14 65.69%
2021-07-17 5 31 26 28.80 17.66 63.08%
2021-07-10 5 31 26 28.80 20.50 40.49%
2021-07-03 5 31 26 28.80 21.58 33.46%
2021-06-26 5 31 26 28.80 21.06 36.75%
2021-06-13 5 31 26 28.80 21.25 35.53%
2021-06-05 5 31 26 28.80 20.42 41.04%
2021-05-22 4 31 26 29.25 20.65 41.65%
2021-05-15 4 32 26 29.75 21.89 35.91%
2021-05-08 4 32 26 29.75 25.65 15.98%
2021-04-25 4 32 26 29.75 25.35 17.36%
2021-04-17 4 32 26 29.75 24.79 20.01%
2021-04-10 4 32 26 29.75 24.59 20.98%
2019-09-16 1 5 5 5.00 NA NA%

INNV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.64 1 3 3 0 0 7

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • INNV has a higher upside potential (average analyst target price relative to current price) than 93.62% of all US stocks.
  • The variance in analysts' estimates of INNV is lower than 16.88% of Healthcare stocks.
  • The average analyst price target of INNV is higher than 31.99% of stocks in the mid market cap category.
  • INNV has a greater number of analysts covering the stock than 38.57% of stocks in the mid market cap category.

In the Healthcare industry, PROG, TLMD and IMAC are the three stocks most similar to InnovAge Holding Corp regarding the price target and analyst recommendation information presented here.

What is the outlook for INNV? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.704 seconds.